Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Decker Robert J | VP Corporate Controller | Aug 30 '24 | Option Exercise | 100.06 | 5,635 | 563,838 | 24,608 | Sep 03 04:48 PM | Decker Robert J | VP Corporate Controller | Aug 30 '24 | Sale | 165.06 | 5,635 | 930,113 | 18,973 | Sep 03 04:48 PM | Decker Robert J | Officer | Aug 30 '24 | Proposed Sale | 165.06 | 5,635 | 930,113 | | Aug 30 03:51 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 08 '24 | Option Exercise | 0.00 | 9,809 | 0 | 24,852 | Jul 09 05:48 PM | REED JOHN C | EVP, Innovative Medicine, R&D | May 01 '24 | Option Exercise | 0.00 | 22,255 | 0 | 22,561 | May 03 04:31 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Mar 13 '24 | Sale | 162.16 | 8,891 | 1,441,765 | 15,043 | Mar 13 04:36 PM | JOHNSON & JOHNSON | 10% Owner | Feb 29 '24 | Option Exercise | 0.72 | 3,855 | 2,792 | 4,103,430 | Mar 06 03:42 PM | JOHNSON & JOHNSON | 10% Owner | Feb 16 '24 | Sale | 25.81 | 3,725 | 96,142 | 4,099,575 | Mar 06 03:42 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13 '24 | Option Exercise | 0.00 | 651 | 0 | 82,599 | Feb 15 04:53 PM | Wolk Joseph J | Exec VP, CFO | Feb 13 '24 | Option Exercise | 0.00 | 1,780 | 0 | 69,663 | Feb 15 04:53 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 13 '24 | Option Exercise | 0.00 | 1,302 | 0 | 155,517 | Feb 15 04:53 PM | Swanson James D. | EVP, CIO | Feb 13 '24 | Option Exercise | 0.00 | 447 | 0 | 14,765 | Feb 15 04:53 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 13 '24 | Option Exercise | 0.00 | 499 | 0 | 13,290 | Feb 15 04:53 PM | Fasolo Peter | Exec VP, Chief HR Officer | Feb 13 '24 | Option Exercise | 0.00 | 925 | 0 | 112,550 | Feb 15 04:53 PM | Hait William | See Remarks | Feb 13 '24 | Option Exercise | 0.00 | 834 | 0 | 39,074 | Feb 15 04:53 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 13 '24 | Option Exercise | 0.00 | 3,470 | 0 | 364,809 | Feb 15 04:53 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 13 '24 | Option Exercise | 0.00 | 408 | 0 | 24,143 | Feb 15 04:53 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 13 '24 | Option Exercise | 0.00 | 651 | 0 | 8,576 | Feb 15 04:53 PM | Decker Robert J | VP Corporate Controller | Feb 13 '24 | Option Exercise | 0.00 | 313 | 0 | 19,059 | Feb 15 04:53 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 12 '24 | Option Exercise | 0.00 | 4,701 | 0 | 25,081 | Feb 14 06:36 PM | Hait William | See Remarks | Feb 12 '24 | Option Exercise | 0.00 | 8,932 | 0 | 42,316 | Feb 14 06:36 PM | Wolk Joseph J | Exec VP, CFO | Feb 12 '24 | Option Exercise | 0.00 | 25,835 | 0 | 78,699 | Feb 14 06:36 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 12 '24 | Option Exercise | 0.00 | 2,859 | 0 | 8,959 | Feb 14 06:36 PM | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Feb 12 '24 | Option Exercise | 0.00 | 26,202 | 0 | 167,618 | Feb 14 06:36 PM | Fasolo Peter | Exec VP, Chief HR Officer | Feb 12 '24 | Option Exercise | 0.00 | 14,960 | 0 | 118,644 | Feb 14 06:36 PM | Swanson James D. | EVP, CIO | Feb 12 '24 | Option Exercise | 0.00 | 5,456 | 0 | 16,013 | Feb 14 06:36 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 12 '24 | Option Exercise | 0.00 | 36,618 | 0 | 377,239 | Feb 14 06:36 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 12 '24 | Option Exercise | 0.00 | 5,736 | 0 | 15,678 | Feb 14 06:36 PM | Decker Robert J | VP Corporate Controller | Feb 12 '24 | Option Exercise | 0.00 | 1,912 | 0 | 19,269 | Feb 14 06:36 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 12 '24 | Option Exercise | 0.00 | 13,813 | 0 | 89,014 | Feb 14 06:36 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 09 '24 | Option Exercise | 90.44 | 130,969 | 11,844,836 | 439,283 | Feb 13 05:18 PM | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 09 '24 | Option Exercise | 90.44 | 59,397 | 5,371,865 | 200,813 | Feb 12 07:25 PM | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 08 '24 | Option Exercise | 0.00 | 3,739 | 0 | 143,329 | Feb 12 07:25 PM | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | Feb 09 '24 | Sale | 156.27 | 59,397 | 9,281,969 | 141,416 | Feb 12 07:25 PM | Duato Joaquin | CEO and Chairman of the Board | Feb 08 '24 | Option Exercise | 0.00 | 5,225 | 0 | 310,583 | Feb 12 07:25 PM | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 08 '24 | Option Exercise | 0.00 | 1,971 | 0 | 67,905 | Feb 12 07:25 PM | Wolk Joseph J | Exec VP, CFO | Feb 08 '24 | Option Exercise | 0.00 | 3,686 | 0 | 53,911 | Feb 12 07:25 PM | Forminard Elizabeth | Executive VP, General Counsel | Feb 08 '24 | Option Exercise | 0.00 | 979 | 0 | 6,463 | Feb 12 07:24 PM | Swanson James D. | See Remarks | Feb 08 '24 | Option Exercise | 0.00 | 1,868 | 0 | 11,111 | Feb 12 07:24 PM | Schmid Timothy | EVP, WW Chair, MedTech | Feb 08 '24 | Option Exercise | 0.00 | 1,964 | 0 | 10,943 | Feb 12 07:24 PM | Fasolo Peter | Exec VP, Chief HR Officer | Feb 08 '24 | Option Exercise | 0.00 | 2,135 | 0 | 104,465 | Feb 12 07:24 PM | Hait William | See Remarks | Feb 08 '24 | Option Exercise | 0.00 | 3,059 | 0 | 34,497 | Feb 12 07:24 PM | Broadhurst Vanessa | EVP, Global Corp Affairs | Feb 08 '24 | Option Exercise | 0.00 | 1,880 | 0 | 21,083 | Feb 12 07:24 PM | Decker Robert J | VP Corporate Controller | Feb 08 '24 | Option Exercise | 0.00 | 655 | 0 | 17,572 | Feb 12 07:24 PM |
|